Victoria Costa Paz on Why Psychedelic Medicine Needs an Infrastructure, Not Just a Drug
Eywa Biotech founder and CEO Victoria Costa Paz explains why bringing psychedelic medicine into mainstream mental health care requires far more than producing pharmaceutical-grade psilocybin. She shares how Eywa is combining biosynthesis, patient tracking, professional education, and treatment infrastructure to build a system around a new model of mental health care.



